Company Search:
Advanced Search
Sponsored Links
Medpace Holdings Inc Company Snapshot
Medpace Holdings Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medpace Holdings Inc with three other companies in this sector in UNITED STATES : Exelixis, Inc. (2019 sales of $967.78 million of which 100% was Oncology focused biotechnology), Genmab A/S ($803.40 million of which 100% was Royalties), and Exact Sciences Corporation ($876.29 million of which 100% was License fees).

Sales Analysis. During the year ended December of 2019, sales at Medpace Holdings Inc were $860.97 million. This is an increase of 22.2% versus 2018, when the company's sales were $704.59 million. This was the fifth consecutive year of sales increases at Medpace Holdings Inc (and since 2014, sales have increased a total of 197%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medpace Holdings Inc
  Stock Performance Chart for Medpace Holdings Inc
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 92.18
(Figures in U.S. Dollars)
1 Week 9.3%   13 Weeks 10.0%  
4 Weeks -7.4%   52 Weeks 64.5%  
Medpace Holdings Inc Key Data:
  Ticker: MEDP Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 860,969,000
(Year Ending Jan 2020).
Employees: 3,500
  Currency: U.S. Dollars Market Cap: 3,270,958,721
  Fiscal Yr Ends: December Shares Outstanding: 35,484,473
  Share Type: Common Closely Held Shares: 8,473,952
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.